Are All Alpha-Blockers Created the Same?
Author:
- 31 March 2006
- journal article
- editorial
- Published by Elsevier in European Urology
- Vol. 49 (3) , 420-422
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparison of the Cardiovascular Effects of Tamsulosin Oral Controlled Absorption System (OCAS®) and Alfuzosin Prolonged Release (XL)European Urology, 2006
- Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: A systematic review of efficacy and adverse effectsUrology, 2005
- Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasiaBJU International, 2005
- The Vasodilatory Effect of Alfuzosin and Tamsulosin in Passive Orthostasis: A Randomised, Double-Blind, Placebo-Controlled StudyEuropean Urology, 2005
- State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaUrology, 2004
- Optimising the Medical Management of Benign Prostatic HyperplasiaEuropean Urology, 2004
- The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic HyperplasiaNew England Journal of Medicine, 2003
- Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trialUrology, 2003
- A Meta-Analysis on the Efficacy and Tolerability of α1-Adrenoceptor Antagonists in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic ObstructionEuropean Urology, 1999